Clinical trials
Completed Phase 2 Schizophrenia Spectrum and Other Psychotic Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Brown University | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Institute on Drug Abuse (NIDA) | 1 |
| Region Örebro County | 1 |
| University of Cologne | 1 |
| University of Manchester | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia Spectrum and Other Psychotic Disorders | 8 |
| Schizophrenia | 6 |
| Mental Disorders | 3 |
| Psychotic Disorders | 2 |
| Tobacco Use Disorder | 2 |
| Schizophrenia, Treatment-Resistant | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.